Paul Chamberlain
About
In The Last Decade
Paul Chamberlain
15 papers receiving 301 citations
Peers
Comparison fields: 5 of 44
- Immunology 167
- Molecular Biology 164
- Biotechnology 113
- Oncology 88
- Radiology, Nuclear Medicine and Imaging 64
Countries citing papers authored by Paul Chamberlain
This map shows the geographic impact of Paul Chamberlain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Chamberlain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Chamberlain more than expected).
Fields of papers citing papers by Paul Chamberlain
This network shows the impact of papers produced by Paul Chamberlain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Chamberlain. The network helps show where Paul Chamberlain may publish in the future.
Co-authorship network of co-authors of Paul Chamberlain
This figure shows the co-authorship network connecting the top 25 collaborators of Paul Chamberlain. A scholar is included among the top collaborators of Paul Chamberlain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Chamberlain. Paul Chamberlain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 6 | |
| 4 | 3 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 0 | |
| 8 | 15 | |
| 9 | 7 | |
| 10 | 76 | |
| 11 | 14 | |
| 12 | 11 | |
| 13 | 29 | |
| 14 | 1 | |
| 15 | 4 | |
| 16 | 1 | |
| 17 | 121 | |
| 18 | 1 | |
| 19 | An overview of scientific and regulatory issues for the immunogenicity of biological products. | 23 |
| 20 | A study of specific IgM antibody response in Mycoplasma pneumoniae infection in man. | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.